スポンサーリンク
Department Of Chest Surgery National Kyushu Cancer Center | 論文
- A New Strategy for Lung Cancer Treatment : Impact of Real-Time Navigation on Thoracoscopic Surgery
- Establishment of a clinical pathway as an effective tool to reduce hospitalization and charges after video-assisted thoracoscopic pulmonary resection
- Intrathoracic Omental Herniation through the Esophageal Hiatus in a Young Patient
- Intratumoral Expression of Macrophage Migration Inhibitory Factor is Correlated with Serum C-Reactive Protein and Interleukin-6 in Patients with Non-Small Cell Lung Cancer
- Video-Assisted Thoracic Surgery Lobectomy for Extralobar Pulmonary Sequestration in a Child : Report of a Case
- Complications and Management of Microwave Coagulation Therapy for Primary and Metastatic Liver Tumors
- Slowly Progressive Adenocarcinoma of the Lung : Report of a Case
- Rib Metastasis Appearing 8 Years After Surgery for Lung Cancer : Report of a Case
- Synovial sarcoma of the chest wall
- Endotracheal Surgery for Leiomyoma of the Trachea
- The Dynamics and Clinical Significance of Alpha 2 Plasmin Inhibitor-Plasmin Complex and Thrombin-Antithrombin Complex in Postoperative Pleural Effusion Following a Pulmonary Lobectomy
- Schwannoma in the peridiaphragm
- Feasibility trial of adjuvant chemotherapy with paclitaxel and carboplatin after surgical resection in Japanese patients with non-small cell lung cancer : report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0501
- Impact of Smoking Status on the Biological Behavior of Lung Cancer
- Diffuse Malignant Pleural Mesothelioma : A Multi-Institutional Clinicopathological Study
- Successful management of postoperative acute respiratory distress syndrome in a patient with lung cancer
- Role of endobronchial ultrasound-guided transbronchial needle aspiration in the management of lung cancer
- Treatment Outcome of Resected and Nonresected Primary Adenoid Cystic Carcinoma of the Lung
- Current Status and Future Direction of Surgical Treatment for Non-Small Cell Lung Cancer
- Early phase ll study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancel